On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Adults in the US who want to measure their blood glucose levels using a wearable sensor ... Dexcom device is not designed to alert users of this “potentially dangerous condition.” It takes the ...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against other high growth large ...

DexCom, Inc. DXCM reported third-quarter 2024 ... The broader S&P 500 index has moved up 21.6% in the same period. Sensor and other revenues (96% of total revenues) increased 9% on a year-over ...

DexCom concluded the third quarter of 2024 on a positive note, with earnings and revenues surpassing expectations. Key drivers included significant contributions from the Sensor segment and robust ...

Every study in these AID systems has been done with the DexCom sensor. So there aren't any head-to-head studies. They've all been run with DexCom, at least with our pump partners, and that's the ...

the company reported that it has submitted a 15-day version of its G7 sensor to the FDA for review. Currently, the device can be worn for up to 10 days among users as young as 2 years old. Dexcom ...

DexCom, Inc. DXCM is scheduled to release third ... Potential robust contributions from the Sensor segment, and domestic and international revenue growth are likely to have been the key catalysts ...

Oct 24 (Reuters) - Medical device maker Dexcom (DXCM.O), opens new tab beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient demand for its continuous ...